Clinical Report

Two cases of renal damage in twin children with co-morbid ANCA-associated vasculitis

  • MA Chenxi ,
  • LIU Jiuyu ,
  • ZHU Yihui ,
  • ZHANG Pei ,
  • GAO Chunlin ,
  • XIA Zhengkun
Expand
  • 1. Jinling Clinical Medical College, Nanjing Medical University, Nanjing 210002, Jiangsu, China
    2. Nanjing University of Information Science and Technology, Nanjing 210044, Jiangsu, China

Received date: 2024-12-06

  Accepted date: 2025-03-18

  Online published: 2025-07-28

Abstract

Pediatric-onset anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of systemic small-vessel vasculitides characterized by ANCA production. Primary AAV in children is rare and is generally considered to arise from immune dysregulation, environmental factors, and infections, with no strong evidence of familial clustering. This report describes a pair of monozygotic twin sisters who developed AAV concurrently. The elder sister, aged 9 years, presented with "anemia for over 20 days and abnormal urinalysis findings for 3 days" and was diagnosed with ANCA-associated vasculitis and ANCA-associated nephritis. The younger sister, screened via urinalysis following her sister's diagnosis, was found to have hematuria and proteinuria, leading to a confirmatory diagnosis. Notably, the sisters exhibited distinct disease subtypes, severity grades, clinical manifestations, and treatment outcomes. The elder sister's renal pathology revealed ANCA-associated renal injury with concurrent immune complex deposits, correlating with poorer renal outcomes. In contrast, the younger sister achieved complete renal recovery after treatment. Extensive exome sequencing failed to identify pathogenic variants in either case.

Cite this article

MA Chenxi , LIU Jiuyu , ZHU Yihui , ZHANG Pei , GAO Chunlin , XIA Zhengkun . Two cases of renal damage in twin children with co-morbid ANCA-associated vasculitis[J]. Journal of Clinical Pediatrics, 2025 , 43(8) : 615 -620 . DOI: 10.12372/jcp.2025.24e1317

References

[1] Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within anca-associated vasculitis[J]. N Engl J Med, 2012, 367(3): 214-223.
[2] Bate S, Mcgovern D, Costigliolo F, et al. The improved kidney risk score in anca-associated vasculitis for clinical practice and trials[J]. J Am Soc Nephrol, 2024, 35(3): 335-346.
[3] Farrukh L, Mumtaz A, Sami F, et al. Familial association of granulomatosis with polyangiitis: a case-based review of literature[J]. Cureus, 2023, 15(6): e40786.
[4] Gomes AM, Nery F, Ventura A, et al. Familial clusters of ANCA small-vessel vasculitis[J]. NDT plus, 2009, 2(1): 34-35.
[5] Zhang P, Yao J, Gao CL, et al. Validation of a renal risk score in a cohort of children with anca-associated glomerulonephritis[J]. J Investig Med, 2023, 71(8): 854-864.
[6] 华胄, 马雁鸿, 陈亮亮, 等. 伴肾小球IgA沉积的抗中性粒细胞胞浆抗体相关性小血管炎的分析[J]. 中华肾脏病杂志, 2018, 34(3): 173-178.
  Hua Z, Ma YH, Chen LL, et al. Clinicopathological features of antineutrophil cytoplasmic antibodies associated vasculitis with glomerular IgA deposits[J]. Zhonghua Shenzangbing Zazhi, 2018, 34(3): 173-178.
[7] Lin W, Shen C, Zhong Y, et al. Glomerular immune deposition in MPO-ANCA associated glomerulonephritis is associated with poor renal survival[J]. Front Immunol, 2021, 12: 625672.
[8] Neumann I, Birck R, Newman M, Schnülle P, et al. SCG/Kinjoh mice: a model of anca-associated crescentic glomerulonephritis with immune deposits[J]. Kidney Int, 2003, 64(1): 140-148.
[9] Bantis C, Stangou M, Schlaugat C, et al. Is presence of anca in crescentic iga nephropathy a coincidence or novel clinical entity? a case series[J]. Am J Kidney Dis, 2010, 55(2): 259-268.
[10] 王培培, 张沛, 高春林, 等. 补体参与儿童肾脏疾病发病机制的再认识[J]. 临床儿科杂志, 2024, 42(5): 467-473.
  Wang PP, Zhang P, Gao CL, et al. Re-recognition of the complement involvement in the pathogenesis of kidney diseases in children[J]. Linchuang Erke Zazhi, 2024, 42(5): 467-473.
[11] Chen M, Jayne Drw, Zhao MH. Complement in anca-associated vasculitis: mechanisms and implications for management[J]. Nat Rev Nephrol, 2017 ;13(6):359-367.
[12] Yu F, Chen M, Wang S-X, et al. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney[J]. Nephrology (Carlton, Vic.), 2007, 12(1):74-80.
[13] 罗丹, 郑智勇. ANCA相关性肾炎合并IgA肾病3例临床病理分析[J]. 诊断病理学杂志, 2016, 23(12): 927-929,935.
  Luo D, Zheng ZY. ANCA-associated glomerulonephritis combined with IgA nephropathy: a clinicopathological analysis of thress cases[J]. Zhenduan Binglixue Zazhi, 2016, 23(12): 927-929,935.
[14] 杨丹, 何志军, 谢永新, 等. ANCA相关性血管炎肾损害合并IgA肾病2例临床病理分析[J]. 诊断病理学杂志, 2022, 29(9): 855-857.
  Yang D, He ZJ, Xie YX, et al. ANCA-associated glomerulonephritis combined with IgA nephropathy: a clinicopathological analysis of thress cases[J]. Zhenduan Binglixue Zazhi, 2022, 29(9): 855-857.
[15] Osman MS, Tervaert JWC. Anti-neutrophil cytoplasmic antibodies (ANCA) as disease activity biomarkers in a “personalized medicine approach” in ANCA-associated vasculitis[J]. Curr Rheumatol Rep, 2019, 21(12): 76.
Outlines

/